Bolt Biotherapeutics, Inc. (BOLT)

Bolt Biotherapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	9.6	7.21	10.81	9.24	27.38	5.54
Short-Term Investments	25.17	40.12	91.38	159.64	158.84	17.3
Cash & Short-Term Investments	34.77	47.32	102.19	168.89	186.22	22.84
Cash Growth	-52.82%	-53.69%	-39.49%	-9.31%	715.39%	-34.42%
Other Receivables	0.1	0.81	0.6	-	-	-
Receivables	0.1	0.81	0.6	-	-	-
Prepaid Expenses	2.68	1.84	2.74	3.86	2.94	2.52
Restricted Cash	0.78	0.78	-	-	-	-
Other Current Assets	-	0.06	0.18	-	-	-
Total Current Assets	38.34	50.81	105.71	172.75	189.16	25.36
Property, Plant & Equipment	22.24	24.9	24.08	28.53	30.6	16.35
Long-Term Investments	13.73	22.88	26.41	23.94	85.35	-
Long-Term Deferred Charges	-	0.05	0.37	-	-	2.36
Other Long-Term Assets	1.2	0.99	3.22	2.59	2.61	2.47
Total Assets	75.5	99.63	159.78	227.81	307.72	46.54
Accounts Payable	1.85	1.51	2.99	3.59	3.57	1.6
Accrued Expenses	5.35	8.34	12.49	15.14	12.38	6.66
Current Portion of Leases	2.56	2.25	2.78	2.39	2.5	1.5
Current Unearned Revenue	2.51	3.02	2.2	1.99	2.87	1.5
Other Current Liabilities	0.04	0.74	-	-	-	-
Total Current Liabilities	12.31	15.86	20.46	23.12	21.33	11.26
Long-Term Leases	21.62	22.96	17.44	20.22	21.85	9.38
Long-Term Unearned Revenue	2.59	3.62	9.11	12.92	14.21	-
Other Long-Term Liabilities	0.13	-	0.04	0.04	0.21	0.33
Total Liabilities	36.66	42.43	47.04	56.3	57.6	20.97
Additional Paid-In Capital	485.85	484.5	476.99	467.51	457.43	3.45
Retained Earnings	-447	-427.4	-364.29	-295.09	-206.99	-108.4
Comprehensive Income & Other	-0.01	0.1	0.04	-0.92	-0.32	-
Total Common Equity	38.84	57.2	112.74	171.51	250.12	-104.95
Shareholders' Equity	38.84	57.2	112.74	171.51	250.12	25.57
Total Liabilities & Equity	75.5	99.63	159.78	227.81	307.72	46.54
Total Debt	24.18	25.21	20.22	22.61	24.36	10.88
Net Cash (Debt)	10.59	22.11	81.97	146.28	161.86	11.96
Net Cash Growth	-80.69%	-73.02%	-43.96%	-9.63%	1253.27%	-51.46%
Net Cash Per Share	5.53	11.58	43.36	78.31	97.52	113.79
Filing Date Shares Outstanding	1.92	1.92	1.91	1.89	1.87	1.82
Total Common Shares Outstanding	1.92	1.92	1.91	1.89	1.87	0.11
Working Capital	26.03	34.96	85.25	149.63	167.83	14.1
Book Value Per Share	20.24	29.84	59.16	90.75	133.75	-985.35
Tangible Book Value	38.84	57.2	112.74	171.51	250.12	-104.95
Tangible Book Value Per Share	20.24	29.84	59.16	90.75	133.75	-985.35
Machinery	8.27	10.13	10.42	10.1	8.26	5.32
Leasehold Improvements	0.29	0.29	0.29	0.27	0.15	-

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q